Effects of pancreaticobiliary diversion and gastric fundectomy on azaserine-induced pancreatic carcinogenesis in the rat
- PMID: 8483875
- DOI: 10.1097/00006676-199305000-00008
Effects of pancreaticobiliary diversion and gastric fundectomy on azaserine-induced pancreatic carcinogenesis in the rat
Abstract
The effects of pancreaticobiliary diversion (PBD) and gastric fundectomy on the pancreas in azaserine-treated rats were studied over 14 months. Sham-operated azaserine-treated animals served as controls. A significant increase in pancreatic weight and total DNA and protein content was found in PBD-operated and fundectomized animals. DNA flow cytometry showed a significantly increased ratio of tetraploid to diploid cells in pancreatic tissue in both experimental groups. Mean values of all these variables were significantly higher after PBD than after fundectomy. Acidophilic atypical acinar cell foci of the pancreas were observed in all of the experimental and 75% of the control animals. The volume density of these foci was significantly higher in each experimental group than in the controls. The volume density, radioactive thymidine labeling index, and mitotic index of the foci were significantly higher after PBD than after fundectomy. Changes consistent with pancreatic adenoma were diagnosed in the PBD group only. It is concluded that not only PBD with endogenous hypercholecystokininemia, but also fundectomy with endogenous hypergastrinemia lasting about half of the life span in rats, induces pancreatic hypertrophy and enhances the development of precancerous pancreatic changes after azaserine treatment. In comparison with PBD, fundectomy caused less pronounced changes and no observable neoplasia.
Similar articles
-
Pancreatic hypertrophy with acinar cell nodules after longterm fundectomy in the rat.Gut. 1993 Jul;34(7):988-93. doi: 10.1136/gut.34.7.988. Gut. 1993. PMID: 8344589 Free PMC article.
-
Chronic endogenous hypercholecystokininemia promotes pancreatic carcinogenesis in the hamster.Carcinogenesis. 1997 Feb;18(2):315-20. doi: 10.1093/carcin/18.2.315. Carcinogenesis. 1997. PMID: 9054623
-
Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.Br J Cancer. 1993 Apr;67(4):663-7. doi: 10.1038/bjc.1993.123. Br J Cancer. 1993. PMID: 8471422 Free PMC article.
-
Inhibitory effects of acetylsalicylic acid on exocrine pancreatic carcinogenesis.Biotech Histochem. 2013 May;88(3-4):132-7. doi: 10.3109/10520295.2012.758779. Epub 2013 Jan 21. Biotech Histochem. 2013. PMID: 23331184 Review.
-
Early indicators of exocrine pancreas carcinogenesis produced by non-genotoxic agents.Mutat Res. 1991 Jun;248(2):291-302. doi: 10.1016/0027-5107(91)90063-t. Mutat Res. 1991. PMID: 2046686 Review.
Cited by
-
Effect of chronic endogenous hypergastrinaemia on pancreatic growth and carcinogenesis in the hamster.Gut. 1997 Apr;40(4):536-40. doi: 10.1136/gut.40.4.536. Gut. 1997. PMID: 9176085 Free PMC article.
-
On the role of cholecystokinin in pancreatic cancer.Int J Pancreatol. 1995 Apr;17(2):121-38. doi: 10.1007/BF02788530. Int J Pancreatol. 1995. PMID: 7622936 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical